AAPL281.62-2.17 (-0.76%) ▼|ABBV253.74+0.39 (+0.15%) ▲|ABT93.48-0.64 (-0.68%) ▼|ACN125.21-3.77 (-2.92%) ▼|ADBE205.52+2.79 (+1.38%) ▲|AMAT697.81+70.97 (+11.32%) ▲|AMD537.18+15.60 (+2.99%) ▲|AMGN359.53+1.20 (+0.33%) ▲|AMT169.07-6.52 (-3.71%) ▼|AMZN240.98+8.29 (+3.56%) ▲|AVGO375.57+10.55 (+2.89%) ▲|AXP341.59+1.23 (+0.36%) ▲|BA215.39-1.86 (-0.86%) ▼|BAC58.12+0.24 (+0.41%) ▲|BKNG183.41+1.95 (+1.07%) ▲|BLK953.48-11.23 (-1.16%) ▼|BMY57.68+0.16 (+0.28%) ▲|BNY144.55+0.99 (+0.69%) ▲|BRK-B496.38-2.28 (-0.46%) ▼|C143.43+1.67 (+1.17%) ▲|CAT1,030.95+33.48 (+3.36%) ▲|CL91.54-0.53 (-0.58%) ▼|CMCSA24.60+1.43 (+6.17%) ▲|COF203.27-0.73 (-0.36%) ▼|COP104.98-0.99 (-0.93%) ▼|COST944.63-7.91 (-0.83%) ▼|CRM158.08-0.29 (-0.18%) ▼|CSCO117.87+4.10 (+3.60%) ▲|CVS103.62-0.72 (-0.69%) ▼|CVX169.70-1.36 (-0.80%) ▼|DE616.09+2.85 (+0.46%) ▲|DHR192.02-4.17 (-2.13%) ▼|DIS98.89+0.10 (+0.10%) ▲|DUK127.92-0.48 (-0.37%) ▼|EMR142.90-0.60 (-0.41%) ▼|FDX324.30+5.77 (+1.81%) ▲|GD349.37+2.66 (+0.77%) ▲|GE373.19+4.19 (+1.13%) ▲|GEV1,103.00+57.83 (+5.53%) ▲|GILD125.85-2.03 (-1.59%) ▼|GM78.28+0.18 (+0.23%) ▲|GOOG351.10+16.41 (+4.90%) ▲|GOOGL353.10+15.71 (+4.66%) ▲|GS1,025.85+6.24 (+0.61%) ▲|HD349.50+0.64 (+0.18%) ▲|HON236.93-6.49 (-2.66%) ▼|IBM276.12+4.49 (+1.65%) ▲|INTC130.75+2.43 (+1.89%) ▲|INTU267.01-0.72 (-0.27%) ▼|ISRG407.62+3.35 (+0.83%) ▲|JNJ256.32+1.66 (+0.65%) ▲|JPM331.28+2.23 (+0.68%) ▲|KO82.24-0.40 (-0.48%) ▼|LIN509.98-9.64 (-1.86%) ▼|LLY1,219.25+11.13 (+0.92%) ▲|LMT505.29-2.11 (-0.42%) ▼|LOW220.59-1.89 (-0.85%) ▼|LRCX410.91+31.82 (+8.39%) ▲|MA511.37+12.35 (+2.47%) ▲|MCD267.39-2.38 (-0.88%) ▼|MDLZ59.84-0.95 (-1.56%) ▼|MDT81.29+0.31 (+0.38%) ▲|META565.86+15.61 (+2.84%) ▲|MMM163.37-0.65 (-0.39%) ▼|MO73.31-0.48 (-0.65%) ▼|MRK128.43-0.23 (-0.18%) ▼|MS213.93+1.90 (+0.89%) ▲|MSFT369.26-3.71 (-0.99%) ▼|MU1,114.47-17.87 (-1.58%) ▼|NEE87.92-0.64 (-0.72%) ▼|NFLX74.32+0.51 (+0.69%) ▲|NKE41.47+0.72 (+1.75%) ▲|NOW100.20+1.86 (+1.89%) ▲|NVDA194.17+1.64 (+0.85%) ▲|ORCL148.58+0.05 (+0.03%) ▲|PEP137.89-3.50 (-2.48%) ▼|PFE24.25-0.04 (-0.16%) ▼|PG147.25-1.77 (-1.19%) ▼|PLTR116.62+3.69 (+3.26%) ▲|PM180.32-0.46 (-0.25%) ▼|QCOM191.17+1.78 (+0.94%) ▲|RTX188.08+0.09 (+0.05%) ▲|SBUX104.23-0.38 (-0.36%) ▼|SCHW90.61-0.06 (-0.07%) ▼|SO96.58-0.58 (-0.60%) ▼|SPG227.21+0.32 (+0.14%) ▲|T21.78-0.94 (-4.15%) ▼|TMO502.85-10.18 (-1.98%) ▼|TMUS175.40-7.28 (-3.99%) ▼|TSLA409.28+29.57 (+7.79%) ▲|TXN289.81+4.39 (+1.54%) ▲|UBER75.02-1.18 (-1.55%) ▼|UNH417.51-10.38 (-2.43%) ▼|UNP270.30+1.95 (+0.73%) ▲|UPS107.70-0.44 (-0.41%) ▼|USB61.31+0.40 (+0.66%) ▲|V341.90+5.67 (+1.69%) ▲|VZ43.85-2.69 (-5.78%) ▼|WFC84.09+0.23 (+0.27%) ▲|WMT114.36-1.33 (-1.15%) ▼|XOM136.74+0.20 (+0.15%) ▲|AAPL281.62-2.17 (-0.76%) ▼|ABBV253.74+0.39 (+0.15%) ▲|ABT93.48-0.64 (-0.68%) ▼|ACN125.21-3.77 (-2.92%) ▼|ADBE205.52+2.79 (+1.38%) ▲|AMAT697.81+70.97 (+11.32%) ▲|AMD537.18+15.60 (+2.99%) ▲|AMGN359.53+1.20 (+0.33%) ▲|AMT169.07-6.52 (-3.71%) ▼|AMZN240.98+8.29 (+3.56%) ▲|AVGO375.57+10.55 (+2.89%) ▲|AXP341.59+1.23 (+0.36%) ▲|BA215.39-1.86 (-0.86%) ▼|BAC58.12+0.24 (+0.41%) ▲|BKNG183.41+1.95 (+1.07%) ▲|BLK953.48-11.23 (-1.16%) ▼|BMY57.68+0.16 (+0.28%) ▲|BNY144.55+0.99 (+0.69%) ▲|BRK-B496.38-2.28 (-0.46%) ▼|C143.43+1.67 (+1.17%) ▲|CAT1,030.95+33.48 (+3.36%) ▲|CL91.54-0.53 (-0.58%) ▼|CMCSA24.60+1.43 (+6.17%) ▲|COF203.27-0.73 (-0.36%) ▼|COP104.98-0.99 (-0.93%) ▼|COST944.63-7.91 (-0.83%) ▼|CRM158.08-0.29 (-0.18%) ▼|CSCO117.87+4.10 (+3.60%) ▲|CVS103.62-0.72 (-0.69%) ▼|CVX169.70-1.36 (-0.80%) ▼|DE616.09+2.85 (+0.46%) ▲|DHR192.02-4.17 (-2.13%) ▼|DIS98.89+0.10 (+0.10%) ▲|DUK127.92-0.48 (-0.37%) ▼|EMR142.90-0.60 (-0.41%) ▼|FDX324.30+5.77 (+1.81%) ▲|GD349.37+2.66 (+0.77%) ▲|GE373.19+4.19 (+1.13%) ▲|GEV1,103.00+57.83 (+5.53%) ▲|GILD125.85-2.03 (-1.59%) ▼|GM78.28+0.18 (+0.23%) ▲|GOOG351.10+16.41 (+4.90%) ▲|GOOGL353.10+15.71 (+4.66%) ▲|GS1,025.85+6.24 (+0.61%) ▲|HD349.50+0.64 (+0.18%) ▲|HON236.93-6.49 (-2.66%) ▼|IBM276.12+4.49 (+1.65%) ▲|INTC130.75+2.43 (+1.89%) ▲|INTU267.01-0.72 (-0.27%) ▼|ISRG407.62+3.35 (+0.83%) ▲|JNJ256.32+1.66 (+0.65%) ▲|JPM331.28+2.23 (+0.68%) ▲|KO82.24-0.40 (-0.48%) ▼|LIN509.98-9.64 (-1.86%) ▼|LLY1,219.25+11.13 (+0.92%) ▲|LMT505.29-2.11 (-0.42%) ▼|LOW220.59-1.89 (-0.85%) ▼|LRCX410.91+31.82 (+8.39%) ▲|MA511.37+12.35 (+2.47%) ▲|MCD267.39-2.38 (-0.88%) ▼|MDLZ59.84-0.95 (-1.56%) ▼|MDT81.29+0.31 (+0.38%) ▲|META565.86+15.61 (+2.84%) ▲|MMM163.37-0.65 (-0.39%) ▼|MO73.31-0.48 (-0.65%) ▼|MRK128.43-0.23 (-0.18%) ▼|MS213.93+1.90 (+0.89%) ▲|MSFT369.26-3.71 (-0.99%) ▼|MU1,114.47-17.87 (-1.58%) ▼|NEE87.92-0.64 (-0.72%) ▼|NFLX74.32+0.51 (+0.69%) ▲|NKE41.47+0.72 (+1.75%) ▲|NOW100.20+1.86 (+1.89%) ▲|NVDA194.17+1.64 (+0.85%) ▲|ORCL148.58+0.05 (+0.03%) ▲|PEP137.89-3.50 (-2.48%) ▼|PFE24.25-0.04 (-0.16%) ▼|PG147.25-1.77 (-1.19%) ▼|PLTR116.62+3.69 (+3.26%) ▲|PM180.32-0.46 (-0.25%) ▼|QCOM191.17+1.78 (+0.94%) ▲|RTX188.08+0.09 (+0.05%) ▲|SBUX104.23-0.38 (-0.36%) ▼|SCHW90.61-0.06 (-0.07%) ▼|SO96.58-0.58 (-0.60%) ▼|SPG227.21+0.32 (+0.14%) ▲|T21.78-0.94 (-4.15%) ▼|TMO502.85-10.18 (-1.98%) ▼|TMUS175.40-7.28 (-3.99%) ▼|TSLA409.28+29.57 (+7.79%) ▲|TXN289.81+4.39 (+1.54%) ▲|UBER75.02-1.18 (-1.55%) ▼|UNH417.51-10.38 (-2.43%) ▼|UNP270.30+1.95 (+0.73%) ▲|UPS107.70-0.44 (-0.41%) ▼|USB61.31+0.40 (+0.66%) ▲|V341.90+5.67 (+1.69%) ▲|VZ43.85-2.69 (-5.78%) ▼|WFC84.09+0.23 (+0.27%) ▲|WMT114.36-1.33 (-1.15%) ▼|XOM136.74+0.20 (+0.15%) ▲|
30.5 C
New York
Monday, June 29, 2026

Tag: patient

newssourceFORcompanyinformationcontent1releasesmarket

Galapagos Bolster Leadership Team with Seasoned Life Sciences Executives to Accelerate Business Transformation

Appoints Sooin Kwon as Chief Business Officer and Dan Grossman as Chief Strategy Officer

iMedX Endorsed by Health New Zealand as Approved Ambient AI Scribe Tool

Partnership with DeliverHealth brings InstaNote (eSOne platform) to New Zealand clinicians AUCKLAND, New Zealand, July 23, 2025 /PRNewswire/ -- iMedX is proud to announce its formal endorsement by Health New Zealand | Te...

Global Data Center Solutions Market Worth to Reach $321.8 Billion by 2030, Driven by 12.8% CAGR: MarkNtel Advisors (Largest Data Center Companies – AWS,...

NEW DELHI, July 23, 2025 /PRNewswire/ -- According to MarkNtel Advisors, the Global Data Center Solutions Market is projected to grow from USD 321.8 billion in...

TraceLink Updates ISO 9001 Certification to Support Scalable, Compliant Supply Chain Innovation

Independent audit confirms TraceLink's operational rigor and readiness to meet evolving customer and regulatory demands BOSTON, July 23, 2025 /PRNewswire/ -- TraceLink, the largest end-to-end digital network...

TraceLink Updates ISO 9001 Certification to Support Scalable, Compliant Supply Chain Innovation

Independent audit confirms TraceLink's operational rigor and readiness to meet evolving customer and regulatory demands BOSTON, July 23, 2025 /PRNewswire/ -- TraceLink, the largest end-to-end digital network...

TraceLink Updates ISO 9001 Certification to Support Scalable, Compliant Supply Chain Innovation

Independent audit confirms TraceLink's operational rigor and readiness to meet evolving customer and regulatory demands BOSTON, July 23, 2025 /PRNewswire/ -- TraceLink, the largest end-to-end digital network...

TraceLink Updates ISO 9001 Certification to Support Scalable, Compliant Supply Chain Innovation

Independent audit confirms TraceLink's operational rigor and readiness to meet evolving customer and regulatory demands BOSTON, July 23, 2025 /CNW/ -- TraceLink, the largest end-to-end digital network...

Aidoc Secures $150M for CARE, its Healthcare Foundation Model, to Transform Clinical Decision-Making for 100 Million Patients

The Era of Clinical AI Has Arrived: Trusted by Leading Health Systems, Aidoc's Platform Brings AI to the Heart of Patient Care NEW YORK, July 23,...

Indivior Real World Evidence Study Finds Medications for Opioid Use Disorder, Particularly Extended-Release Buprenorphine, Reduced Odds of Emergency Department Visits for Patients with Opioid...

Extended-release buprenorphine (BUP-XR) had lower rates of hospitalizations, emergency department (ED) visits, and outpatient physician office visits compared to those receiving daily oral buprenorphine or no medications for...

Clearside Biomedical Announces Approval of XIPERE® Suprachoroidal Treatment for Uveitic Macular Edema in Canada

- XIPERE Now Approved for Use in Multiple Global Markets -

Global Dental Leaders to Convene in Shanghai for FDI World Dental Congress 2025

SHANGHAI, July 23, 2025 /PRNewswire/ -- The FDI World Dental Congress (WDC), one of the world's premier events for the oral health profession, will...

4TEEN4 Doses First Patient in Phase 1b/2a Trial of Procizumab, a Monoclonal Antibody Targeting the Biological Driver of Shock

Hennigsdorf/ Berlin, July 23, 2025 – 4TEEN4 Pharmaceuticals GmbH today announced that the first patient has been dosed in a Phase 1b/2a PROCARD1 clinical trial evaluating its monoclonal antibody, procizumab, in patients with shock caused primarily by cardiogenic events. Shock is a life-threatening condition characterized by a sudden breakdown in circulatory function due to end-stage disease or acute events, which often leads to organ failure. With only symptomatic treatment options available, shock is associated with a high mortality rate of over 50%. The Phase 1b/2a trial is designed to identify a target dose for procizumab in preparation for further clinical development. In addition, the trial will provide signals of efficacy. In a Phase 1 study in healthy volunteers, procizumab was well tolerated.

Global Dental Leaders to Convene in Shanghai for FDI World Dental Congress 2025

SHANGHAI, July 23, 2025 /PRNewswire/ -- The FDI World Dental Congress (WDC), one of the world's premier events for the oral health profession, will...

Singapore-Based Innovative Biomedical Start-Up Achieves ‘Strategic Triumph’ to Conquer Chinese Med-Tech Market

NMPA grants Syntellix product approval for the world's most important future market with more than 1.4 billion people Syntellix' product approval for China...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPatient

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers